Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing He

Showing results (1181-1190 of 1,198) with videos related to

Pageof 120
Sort By:
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Journal of Pharmaceutical Sciences|October 5, 2007
N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerationsKan He, Mingxin Qian, Harvey Wong, et al.
Cell Host & Microbe|March 21, 2026
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B virusesXiaoyu Cai, Miao Fan, Yanmei Zhai, et al.
Diabetologia|March 6, 2014
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetesNiina Sandholm, Carol Forsblom, Ville-Petteri Mäkinen, et al.
Diabetologia|May 30, 2014
Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classificationFrancesco Sambo, Alberto Malovini, Niina Sandholm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2023
Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosisChao Li, Qiu-Ying Ma, Xue-Qi Liu, et al.
Nature Communications|November 15, 2017
mTOR intersects antibody-inducing signals from TACI in marginal zone B cellsJordi Sintes, Maurizio Gentile, Shuling Zhang, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
Nature Communications|March 8, 2016
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Pageof 120

Showing results (1181-1190 of 1,198) with videos related to

Sort By:
Pageof 120
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Journal of Pharmaceutical Sciences|October 5, 2007
N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerationsKan He, Mingxin Qian, Harvey Wong, et al.
Cell Host & Microbe|March 21, 2026
Human monoclonal antibodies isolated after seasonal vaccination broadly neutralize antigenically drifted influenza B virusesXiaoyu Cai, Miao Fan, Yanmei Zhai, et al.
Diabetologia|March 6, 2014
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetesNiina Sandholm, Carol Forsblom, Ville-Petteri Mäkinen, et al.
Diabetologia|May 30, 2014
Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classificationFrancesco Sambo, Alberto Malovini, Niina Sandholm, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 7, 2023
Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosisChao Li, Qiu-Ying Ma, Xue-Qi Liu, et al.
Nature Communications|November 15, 2017
mTOR intersects antibody-inducing signals from TACI in marginal zone B cellsJordi Sintes, Maurizio Gentile, Shuling Zhang, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
Nature Communications|March 8, 2016
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationDefang Li, Jin Liu, Baosheng Guo, et al.
Pageof 120